HUYABIO International, the leader in accelerating global development of China’s pharmaceutical innovations, today announced the successful completion of a Phase …
Corbus Pharmaceuticals Holdings, Inc., an immunology company, announced that new preclinical data for CRB-601 are being presented today in an …
Phio Pharmaceuticals Corp., a clinical stage biotechnology company developing the next generation of therapeutics based on its proprietary self-delivering RNAi …
Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as ‘Lynk Pharmaceuticals’), an innovative clinical stage company, announced that its Class I …
The partner of CStone Pharmaceuticals, Servier, today announced the publication of results from the Phase 3 AGILE trial of TIBSOVO® …
LAGUNA HILLS, Calif. and SHANGHAI and BOCHUM, Germany, April 21, 2022 /PRNewswire/ — Wallaby Medical (“Wallaby” or the “Company”), a global …
TetraScience, the R&D Data Cloud company, announced today that RockStep Solutions, a leading provider of research management software designed for …
– Core Material Used for Targeted Alpha Therapy (TAT) Expected to Be Novel Treatment for Cancer – TOKYO, April 5, 2022 …
Perrigo Company plc, a leading provider of Quality, Affordable Self-Care Products, today announced that it has launched the syndication of …
Ascletis Pharma Inc. (HKEX: 1672) today announces the business update on its oral double prodrug ASC10 against Coronavirus Disease 2019 …
